KNKouhei Nagai

Kouhei Nagai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kouhei Nagai has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Atsuhiro Tsutiya

    Clinical Proteomics and Molecular Medicine, St. Marianna University Graduate School of Medicine, 2-16-1 Sugao, Miyamae, Kawasaki 216-8511, Kanagawa, Japan

    2 shared publications
  • Manae Suzuki Kurokawa

    Clinical Proteomics and Molecular Medicine, St. Marianna University Graduate School of Medicine, 2-16-1 Sugao, Miyamae, Kawasaki, Kanagawa, 216-8511, Japan

    2 shared publications
  • Mitsumi Arito

    Clinical Proteomics and Molecular Medicine, St. Marianna University Graduate School of Medicine, 2-16-1 Sugao, Miyamae, Kawasaki, Kanagawa, 216-8511, Japan

    2 shared publications
  • Kazuki Omoteyama

    Clinical Proteomics and Molecular Medicine, St. Marianna University Graduate School of Medicine, Kawasaki, Kanagawa, Japan

    1 shared publication
  • Kazuki Omoteyama

    Clinical Proteomics and Molecular Medicine, St. Marianna University Graduate School of Medicine, 2-16-1 Sugao, Miyamae, Kawasaki, Kanagawa, 216-8511, Japan

    1 shared publication
  • Kimito Kawahata

    Department of Rheumatology and Allergology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan

    1 shared publication

Latest Publications

  • Proximity-dependent biotin identification (BioID) screening identified novel layilin-proximal proteins

    by Atsuhiro Tsutiya, Kouhei Nagai, Masaaki Sato, Kazuki Omoteyama, Toshiyuki Sato, Naoya Suematsu, Manae S. Kurokawa, Tomohiro Kato, Mitsumi Arito

  • Open Access

    Serum peptides as candidate biomarkers for relapsing polychondritis

    by Toshiyuki Sato, Masaaki Sato, Kouhei Nagai, Masahiko Fukasawa, Yoshiaki Nagashima, Teisuke Uchida, Atsuhiro Tsutiya, Kazuki Omoteyama, Mitsumi Arito, Yukiko Takakuwa, et al.

    Relapsing polychondritis (RP) is an intractable disease characterized by recurrent inflammation of cartilaginous tissue throughout the body. It is difficult to accurately diagnose RP, and no useful biomarkers have yet been identified. We analyzed serum peptide profiles to identify novel candidate biomarkers for RP. Thirty-seven patients with RP, 42 patients with rheumatoid arthritis (RA), and 35 healthy control (HC) subjects were divided into training and testing sets. Seven patients demonstrating granulomatosis with polyangiitis (GPA) were used for validation. The ion intensity of serum peptides was comprehensively measured by matrix-assisted laser desorption/ionization time-of-flight/time-of-flight mass spectrometry and applied to a supervised multivariate analysis. Peptides of interest were analyzed by liquid chromatography-tandem mass spectrometry. In the training set, models developed based on 11 (RP/HC-11P model), 9 (RP/RA-9P model), and 14 (RP/nonRP-14P model) peptides, out of 160 peptides detected were able to completely discriminate the RP group from the HC, RA, and nonRP (HC + RA) groups. Almost all of the 15 identified discriminatory peptides comprising these models were fragments of proteins associated with coagulation. Four models, each consisting of 4 out of 10 identified peptides of the RP/nonRP-14P model (models RP/nonRP-4P-2, -10, -11, and -38), provided ≥ 70.0 % sensitivity and specificity when applied to the validation set (the testing set and the GPA group) (AUROC, 0.779–0.815). Notably, the RP/nonRP-4P-2 model provided 83.3 % sensitivity and 71.7 % specificity in the validation set (AUROC, 0.802). Serum peptides are useful as candidate biomarkers for discriminating RP and may be involved in the pathophysiology of RP.